EU regulator clears Pfizer-BioNTech's tweaked COVID booster
The European Medicines Agency has recommended the authorization of a tweaked booster dose of the Pfizer-BioNTech coronavirus vaccine that includes protection against two of the latest versions of omicron, as countries look to bolster their immunization programs ahead of winter.
EXPLAINER: Should you get a new COVID booster? If so, when?
The University of Pennsylvania immunologist knows it's too soon after his shot late this summer, especially since he's not at high risk from the virus. It’s the kind of calculation many Americans will face as booster shots that target currently circulating omicron strains become available to a population with widely varying risks and levels of immunity. HOW ARE THE NEW BOOSTERS DIFFERENT?news.yahoo.com
Pfizer excludes Asian, white applicants from 9-year scholarship program
Pfizer has excluded Asian and white applicants in its new “Breakthrough Fellowship Program,” a nine-year commitment that aims to boost minority representation in its workforce. Available to undergraduate students in their junior year, the program will offer an initial 10-week summer internship, two years of full-time employment after undergraduate graduation, a fully paid two-year MBA, MPH or MS Statistics program, another summer internship between the first and second years of the chosen master’s program, and finally, employment with Pfizer after graduation. Aside from obtaining their undergraduate degree in December 2023 or Spring 2024, applicants must be U.S. citizens or U.S. permanent residents, have a GPA of at least 3.0, demonstrate exceptional leadership potential and have a committed interest in pursuing an MBA, MPH or MS Statistics program.news.yahoo.com
Pfizer seeks OK of updated COVID vaccine booster for fall
Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives — a key step toward opening a fall booster campaign. The Food and Drug Administration ordered vaccine makers to tweak their shots to target BA.4 and BA.5 that are better than ever at dodging immunity from earlier vaccination or infection. If the FDA quickly clears the combo shots made by Pfizer and its partner BioNTech, boosters could be offered within weeks.news.yahoo.com
Pfizer asks FDA to authorize Covid booster shots that target omicron BA.5 for people ages 12 and older
Pfizer and its German partner BioNTech on Monday asked the Food and Drug Administration to authorize Covid booster shots that target the omicron BA.4 and BA.5 subvariants for people ages 12 and older. The U.S. is preparing for a fall vaccination campaign using updated vaccines that target the dominant omicron subvariants. The updated vaccines would target the original strain of the virus that first emerged in Wuhan, China in 2019 as well as omicron. Scientists and public health officials hope the new shots will provide broader and more durable protection against infection and mild illness. The currently authorized shots were developed to target the version of Covid that first emerged in China.cnbc.com
The Brazilian Scientists Inventing An mRNA Vaccine — And Sharing The Recipe : Short Wave
When Moderna and Pfizer first came out with their mRNA vaccines for COVID-19, supply was limited to rich countries and they did not share the details of how to create it. That left middle income countries like Brazil in the lurch. But for Brazilian scientists Patricia Neves and Ana Paula Ano Bom, that wasn't the end. They decided to invent their own mRNA vaccine. Their story, today: Aaron talks to global health correspondent Nurith Aizenman about the effort and how it has helped launch a wider global project to revolutionize access to mRNA vaccine technology.npr.org
Biden tests positive for COVID-19, has 'mild symptoms'
President Joe Biden tested positive for COVID-19 on Thursday, underscoring the persistence of the highly contagious virus as new variants challenge the nation's efforts to resume normalcy after two and a half years of pandemic disruptions. White House Press Secretary Karine Jean-Pierre said that Biden was experiencing “mild symptoms" and has begun taking Paxlovid, an antiviral drug designed to reduce the severity of the disease. Biden, 79, is fully vaccinated, after getting two doses of the Pfizer coronavirus vaccine shortly before taking office, a first booster shot in September and an additional dose March 30.news.yahoo.com